Kilkenny

where business moves faster

Ireland now has a globally significant Life Sciences sector and is home to operations by some of the world's leading pharmaceutical, biotechnology and medical technology companies.

 

Glanbia LabWithin the Life Sciences sector, an enviable cluster has grown in the South East region of Ireland. Among the companies who make up this cluster are Genzyme, Teva Pharmaceuticals, Glaxo Smith Kline, Hypro Medical Devices and Merck Sharpe & Dohme. A strong and skilled labour pool, competitively priced property options, robust telecommunications infrastructure and attractive incentives have made the South East region a location or choice for pharmaceutical companies.

 

The Belview development zone in South Kilkenny is strategically located within the region, just 4 miles from Waterford City and adjoining Belview Port, Ireland's closest deep-water port to Europe. Belview is the ideal location for life sciences industry and incorporates 265 hectares of zoned land, including a strategic IDA site of 27 hectares, the Marine Point Business Park and Belview Port.  The IDA's Belview site is available for pharmaceutical, industry and technology use.  Recently, Glanbia PLC commenced a €150m investment project at Belview for a dairy ingredients facility, tapping into further developing the Asia Pacific market.

 

Life science companies locating in Belview benefit from an exceptional transport infrastructure with immediate access to the national motorway system bringing Dublin and Cork within a 90 minute drive.  Belview has all the infrastructure necessary for high volume production and  is supported by significant water and waste water capabilities as well as being serviced by a high capacity fibre optic network.

 

Belview has excellent access to the Waterford City gateway, a city with a population of 50,000 and there are three third level facilities within 50 minutes drive producing 3,500 graduates per year. Waterford Institute of Technology (WIT) offers significant research expertise capability  locally to the sector through its Pharmaceutical and Molecular Biotechnology Research Centre (PMBRC) which focusses on areas such as polymeric materials, drug delivery, process technologies, separation science and molecular biotechnology. The PMBRC collaborates with leading players in the region such as Genzyme, Merck Sharp & Dohme and EirGen Pharma on industry projects and acts as a focal point for stimulating research and innovation.